Whether copay cards count toward your deductible depends on your specific health plan. Some plans still treat a manufacturer’s payment at the pharmacy counter the same as a payment from your wallet, applying it to your deductible and out-of-pocket maximum. A growing number of plans use “copay accumulator” or “copay maximizer” programs that accept the manufacturer’s money but credit none of it to your cost sharing. More than 20 states have banned that practice, but the ban often doesn’t reach the plan you’re actually on.
The quickest way to know where you stand is to check your plan documents and call your pharmacy benefit manager before your next fill. The sections below explain what you’re looking for and why the answer varies so much from person to person.
What Changed and Why Your Plan Might Not Count the Card
A copay card is a subsidy from a drug manufacturer that covers part or all of your out-of-pocket cost for a specific brand-name medication. Each card has an annual dollar cap, often running from a few thousand dollars to more than $15,000 depending on the drug.
Traditionally, a payment from a copay card was treated the same as a payment from you. The pharmacy collected the money, the insurer saw a cost-sharing obligation fulfilled, and your deductible balance dropped. Someone on an expensive specialty medication could satisfy a $5,000 deductible in a few fills without spending a dime of their own money.
Insurers and pharmacy benefit managers (PBMs) started pushing back on that math. Their position is that manufacturer payments aren’t your money, so they shouldn’t count as your cost sharing. Counting the card means the plan starts paying sooner, which costs the plan more. Two program designs now carry out that policy.
Copay Accumulator Programs
An accumulator program tracks every dollar that comes from a manufacturer’s card and strips it out of your deductible and out-of-pocket calculations. You still hand the card to the pharmacist and the manufacturer still pays, but none of that money counts toward anything on your side of the ledger. Someone filling a $3,000-per-month medication with a $10,000 copay card might pay $0 at the counter in January, February, and March. In April the card is exhausted, and the full $3,000 fill lands on an untouched deductible.
Copay Maximizer Programs
Maximizer programs spread the card’s annual value evenly across the plan year. If a card has a $15,000 annual benefit and the patient fills monthly, the PBM sets the patient’s monthly copay at roughly $1,250 per fill, calibrated so the card covers exactly that amount each time. You pay $0 every month for the full year, which sounds fine until you notice the deductible never moved. The copay was engineered to match the card’s value, not to satisfy the deductible or out-of-pocket maximum.
How to Tell Whether Your Plan Credits Copay Assistance
Don’t wait until your copay card runs out to find this out. A few steps now can save you from a four-figure surprise six months into the year.
Start by figuring out whether your plan is self-funded or fully insured, because that controls whether your state’s accumulator rules apply. Call the number on the back of your insurance card and ask directly, or check with your employer’s HR or benefits department. Your Summary Plan Description should state which type it is.
Next, search your plan documents for accumulator language. Insurers rarely advertise these programs in plain terms. Look in your Summary of Benefits and Coverage or Evidence of Coverage for phrases like “copay accumulator adjustment,” “coupon adjustment,” “out-of-pocket protection program,” “benefit plan protection program,” or “copay leveling program.” Any of those signals that manufacturer assistance won’t count toward your deductible.
Then call your PBM at the pharmacy benefit number on your card and ask a direct question: if you use a manufacturer copay card for a specific prescription, will the amount the card pays be applied to your deductible and out-of-pocket maximum? Get the answer in writing if you can. Verbal assurances from a phone representative are hard to enforce later.
Finally, track the numbers yourself. Log in to your insurer’s portal after each fill and confirm that your deductible balance reflects the payment. If it doesn’t, you have evidence of an accumulator in action and can start planning for the point when the card runs dry.
State Laws and the ERISA Gap
As of late 2024, at least 21 states and Puerto Rico had enacted “all copays count” laws requiring insurers to apply manufacturer copay assistance toward patients’ deductibles and out-of-pocket maximums. The laws vary in detail, but the core requirement is the same: any payment made on your behalf must reduce your cost-sharing balance, regardless of where the money came from.
There’s a significant catch. State insurance laws only govern fully insured health plans, where the employer buys a policy from a state-regulated insurance company. If your employer self-funds its health plan, meaning the company pays claims directly rather than purchasing insurance, your plan is governed by a federal law called the Employee Retirement Income Security Act. ERISA broadly preempts state insurance regulation of self-funded plans.1Office of the Law Revision Counsel. 29 U.S. Code 1144 – Other Laws So even if your state has an all-copays-count law on the books, it likely doesn’t apply to your plan if your employer is large enough to self-fund.
Most large employers do self-fund. If you work for a company with several hundred or more employees, there’s a good chance your plan falls outside state accumulator protections entirely.
Federal Rules Are Still in Flux
The gap left by ERISA preemption has pushed the fight to the federal level, and the federal rules are not yet settled.
In a 2023 case, patient advocacy groups sued the Department of Health and Human Services, arguing that the Affordable Care Act already requires all payments, including manufacturer copay assistance, to count toward the ACA’s out-of-pocket maximum. The federal district court in Washington, D.C. ruled in the plaintiffs’ favor in September 2023, but the government appealed and the case remained in the appeals process as of early 2026.
The court’s reasoning included a notable exception: copay assistance for brand-name drugs with a medically appropriate generic equivalent available does not have to count toward cost sharing. If you’ve tried the generic and it didn’t work for you, the exception shouldn’t apply, but proving that to your insurer takes documentation.
On the legislative side, the bipartisan HELP Copays Act was introduced in March 2025. The bill would amend the ACA’s definition of cost sharing to specify that payments made “by or on behalf of” a patient, including from manufacturers and nonprofit organizations, must count toward deductibles and out-of-pocket maximums.2Kaine.Senate.gov. Kaine, Marshall Introduce Bipartisan Legislation to Protect Patients from High Drug Costs If enacted, it would reach self-funded ERISA plans that currently sidestep state laws. As of mid-2026 the bill has not been enacted.
The HSA and High Deductible Health Plan Wrinkle
If you have a Health Savings Account paired with a High Deductible Health Plan, the answer gets more tangled. To qualify for HSA contributions, your HDHP must meet IRS minimums: for 2026, the annual deductible must be at least $1,700 for individual coverage or $3,400 for family coverage, and out-of-pocket expenses can’t exceed $8,500 for an individual or $17,000 for a family.3IRS.gov. Notice 2026-5 – Expanded Availability of Health Savings Accounts Under the OBBBA
Here’s the tension. An HDHP generally cannot pay benefits, other than preventive care, before you’ve satisfied the minimum deductible.4Office of the Law Revision Counsel. 26 U.S.C. 223 – Health Savings Accounts If a state law forces your plan to count a manufacturer’s copay card toward the deductible, the plan might effectively start covering your medication before you’ve personally spent $1,700, which could disqualify the plan as an HDHP and jeopardize your HSA contributions.
Some state accumulator ban laws address this by carving out an exception for HSA-qualified HDHPs, so manufacturer assistance only counts toward cost sharing after you’ve met the IRS minimum deductible from your own pocket. If your state doesn’t include that carve-out, or you’re in a self-funded plan where the state law doesn’t apply anyway, pay close attention to how your plan treats the interaction.
If Your Plan Doesn’t Count the Card
You have options beyond bracing for the mid-year bill.
Ask your prescriber about generic alternatives. If a generic equivalent exists and works for you, the cost-sharing question largely disappears because the per-fill cost drops dramatically. Not every medication has a viable generic, and for many specialty drugs there is none, but it’s worth a conversation.
Budget for the deductible gap. If you know your copay card has a $10,000 annual benefit and your medication costs $3,000 per fill, you can estimate when the card will run out. Start setting money aside for the uncovered months. If you have an HSA or flexible spending account, consider front-loading contributions.
Look into independent charitable foundations. Organizations such as The Assistance Fund and similar nonprofits provide copay help that is separate from manufacturer programs. Many of them can also help patients on government insurance, provided the patient meets income and diagnosis requirements, and their payments typically don’t raise the same accumulator issues.
File a complaint when applicable. If your plan is fully insured and your state has an all-copays-count law, your insurer is legally required to credit manufacturer payments toward your cost sharing. Contact your state Department of Insurance if the insurer refuses. For self-funded plans, you can file a complaint with the U.S. Department of Labor, which oversees ERISA plans, though current federal rules give insurers more latitude.
A Boundary for Medicare and Medicaid Patients
Manufacturer copay cards are only available to people with commercial insurance. Federal law prohibits manufacturers from offering copay assistance to anyone enrolled in Medicare, Medicaid, or other federal healthcare programs. The federal Anti-Kickback Statute treats such payments as illegal inducements when a federal program is paying for the drug.5Office of the Law Revision Counsel. 42 U.S. Code 1320a-7b – Criminal Penalties for Acts Involving Federal Health Care Programs Independent charitable foundations can still help patients on government programs.
If you switch from commercial insurance to Medicare mid-year, your manufacturer copay card becomes immediately unusable. Assistance received under your commercial plan does not transfer to Medicare’s cost-sharing calculations, and payments a manufacturer’s patient assistance program makes on behalf of a Medicare beneficiary do not count toward Part D’s true out-of-pocket costs.6Centers for Medicare & Medicaid Services. Pharmaceutical Manufacturer Patient Assistance Program Information Plan the transition carefully to avoid a gap in access to your medication.